Complanatoside A is primarily studied for its anti-inflammatory and neuroprotective properties. It has shown potential in inhibiting key inflammatory pathways, making it a candidate for development in treating neurodegenerative conditions such as Alzheimer’s disease. Research indicates it may help reduce oxidative stress and suppress the activation of microglial cells in the brain, which are involved in neuroinflammation. Additionally, complanatoside A exhibits antioxidant activity, contributing to cellular protection against damage caused by free radicals. These characteristics suggest its relevance in pharmaceuticals targeting brain health and chronic inflammatory diseases.